CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 233 enrolled
Drug / intervention
Resistance Exerciseother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04900961
NCT04900961N/ACompleted

Prevention and Early Treatment of the Long-term Physical Effects of Coronarvirus-19 (COVID-19): a Randomised Clinical Trial of Resistance Exercise.

NHS Greater Glasgow and Clyde·interventional·Posted May 25, 2021·Updated Feb 25, 2025

In Brief

A clinical study evaluating Resistance Exercise for Covid19. Completed, enrolled 233 participants across 2 sites.

Detailed Summary

Many people have long-lasting symptoms after COVID-19, such as breathlessness, fatigue and chest pain. So far, research studies of treatments for COVID-19 have focused on the life-threatening acute illness; few studies look at treatments to improve long-term health after COVID-19. COVID-19, particularly when this requires a hospital admission, can lead to weight loss and muscle wasting, contributing to worse outcomes. Muscle strengthening (resistance-based) exercise could improve outcomes in the long-term.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 25, 2021
Enrollment StartJun 1, 2021
Primary CompletionAug 30, 2024
Study CompletionFeb 21, 2025
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 5.1 years ago

Interventions

Resistance Exerciseother

The exercise regimens are generic and designed not to require expert physiotherapy input, therefore, the availability of NHS physiotherapists, which may be at times limited, will not be a barrier to implementation